Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
MRK News
Verona Pharma (VRNA), which entered into a definitive agreement on July 8 relating to its proposed acquisition by Merck (MRK) through a wholly owned subsidiary...
Merck (MRK) announced it has initiated three Phase 2b trials evaluating the safety and efficacy of tulisokibart, an investigational humanized monoclonal antibod...
Earlier this week, Merck announced highly positive results from its Phase 3 HYPERION trial, showing that WINREVAIR, when combined with background therapy, signi...
Analyst ratings
57%
of 28 ratingsMore MRK News
Merck (MRK) shares have seen notable swings recently, leaving investors curious about what might be driving the movement. Looking at recent performance trends,...
Worried about sliding interest on your savings? These three Dow stocks are yielding more than 4%. Verizon (VZ -1.25%) is currently the highest-yielding stock i...
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the November 14th expiration. At Stock Options Channel , our YieldBoost fo...
In trading on Thursday, shares of Merck & Co Inc (Symbol: MRK) crossed above their 200 day moving average of $108.16, changing hands as high as $108.85 per shar...
Merck & Co. Inc. (NYSE:MRK) announced results Tuesday from its Phase 3 HYPERION trial evaluating Winrevair (sotatercept-csrk) versus placebo (both in combinatio...
Merck (MRK) announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR versus placebo in recently diagnosed adults with pulmonary arterial...